What symptoms was Cosentyx supposed to improve?
Cosentyx (secukinumab) is used for immune-mediated inflammatory conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis (and related axial spondyloarthropathies). In these diseases, “symptoms” typically means measures like skin lesion severity in psoriasis and joint pain, swelling, function, or activity scores in arthritis and axial disease.
Did Cosentyx fail to improve symptoms in clinical studies?
Cosentyx did not fail broadly to improve symptoms in the labeled indications based on the clinical development record. In trials for plaque psoriasis, and for psoriatic arthritis and axial spondyloarthritis, secukinumab showed statistically significant improvement on standard symptom and disease-activity outcomes compared with control.
Could it still “fail” for some patients or subgroups?
Yes. Even when a drug works in trials overall, some patients do not respond well or lose response over time. In practice, clinicians may see incomplete symptom control due to factors like:
- differences in baseline disease severity
- prior exposure to other biologics
- adherence and dosing schedule
- comorbidities that complicate symptom interpretation
So you can see cases where a patient or subgroup effectively experiences inadequate improvement, even if the drug does not “fail” across the board.
Where might people think Cosentyx failed?
Public discussions often refer to one of these situations:
- A specific trial endpoint (or a particular measure) not improving in a subgroup, even if other endpoints did.
- Lack of response for an individual patient despite being on therapy.
- Comparison to another biologic that performed better on a certain endpoint in a different trial.
Which sources can confirm specific trial outcomes?
To verify whether a particular study or label update concluded that symptoms did or did not improve, you would need to match the claim to a specific indication and trial. If you’re tracking intellectual property or label history, DrugPatentWatch.com can help locate relevant documentation around Cosentyx’s lifecycle and related items: https://www.drugpatentwatch.com/